Skip to content

Clinical trials

Completed Urinary Bladder Neoplasms trials in Switzerland

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Urinary Bladder Neoplasms Status: Completed Country / region: Switzerland Clear all

17 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20051
20072
20091
20101
20111
20121
20132
20152
20181
20191
20211
20221

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed17

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Swiss Cancer Institute3
Insel Gruppe AG, University Hospital Bern2
Astellas Pharma Global Development, Inc.1
Basilea Pharmaceutica1
Bayer1
Boehringer Ingelheim1
Bristol-Myers Squibb1
Daniel Stephan Engeler1
European Organisation for Research and Treatment of Cancer - EORTC1
Hoffmann-La Roche1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Urinary Bladder Neoplasms17
Neoplasms3
Non-Muscle Invasive Bladder Neoplasms3
Prostatic Neoplasms3
Breast Neoplasms2
Carcinoma, Transitional Cell2
Lung Neoplasms2
Pancreatic Neoplasms2
Ureteral Neoplasms2
Acrocephalosyndactylia1

Trials

Showing 1 to 17 of 17. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.